Heparin contamination and the FDA

2026 Election HubYour ballot, voting information and the latest updates
Heparin
FDA Commissioner Andrew von Eschenbach testifies on Capitol Hill in Washington, DC. The hearing was to examine whether the FDA is adequately regulating overseas pharmaceutical product manufacture after 81 deaths in the U.S. associated with tainted heparin.
Photo by Alex Wong/Getty Images